Paragraph IV Challenges
✉ Email this page to a colleague
Tradename | Dosage | Generic Name | NDA | ANDAs Submitted | 180 Day Exclusivity Status | Submissiondate |
---|---|---|---|---|---|---|
KLOXXADO | Nasal Spray | naloxone hydrochloride | 212045 | 1 | 2023-03-30 | |
SPRAVATO | Nasal Spray | esketamine hydrochloride | 211243 | 3 | 2023-03-06 | |
SUTAB | Tablets | magnesium sulfate; potassium chloride; sodium sulfate | 213135 | 1 | 2023-03-03 | |
PHEXXI | Vaginal Gel | citric acid; lactic acid; potassium bitartrate | 208352 | 1 | 2023-02-28 | |
>Tradename | >Dosage | >Generic Name | >NDA | >ANDAs Submitted | >180 Day Exclusivity Status | >Submissiondate |